Macrogenics Inc

Ownership Transactions Reported by 21 Insiders

Symbol
MGNX on Nasdaq
Location
9704 Medical Center Drive, Rockville, MD

Insiders trading volume in the past year

Macrogenics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Biotech Target N V 10%+ Owner $119M Oct 2, 2023
Scott Koenig Director $1.3M Aug 13, 2025
Lynn Cilinski VP, Controller and Treasurer $1.16M Feb 15, 2024
James Karrels SVP, CFO and Secretary $1.04M Feb 15, 2025
Stephen L. Eck Chief Medical Officer $698K Feb 15, 2025
Edward Hurwitz Director $365K May 20, 2025
Ezio Bonvini Sr VP, Research & CSO $361K Feb 15, 2025
William K. Heiden Director $333K +$151K +82.5% Aug 19, 2025
David C. Stump Director $306K May 20, 2025
Karen Jean Ferrante Director $306K May 20, 2025
Scott Thomas Jackson Director $306K May 20, 2025
Federica F. O'Brien Director $249K May 20, 2025
Meenu Chhabra Director $229K May 20, 2025
Margaret Liu Director $199K May 20, 2025
Jay Philip Siegel Director $199K May 20, 2025
Eric Blasius Risser President and CEO, Director $186K Aug 13, 2025
Thomas Spitznagel Sr VP, Technical Ops $88.9K Aug 15, 2025
Jeffrey Stuart Peters Senior VP and General Counsel $69.2K Aug 15, 2025
Beth Smith VP, Controller & Treasurer $27.2K -$1.08K -3.83% Feb 15, 2025
Paulo F. Costa Director $22.7K May 13, 2021
Kenneth Galbraith Director $22.7K May 13, 2021

Recent Insider Transactions by Companies or Individuals for Macrogenics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.